Key result
African tobacco smoking projected to rise significantly by 2025, escalating regional cardiovascular disease risks.
Why the study?
Tobacco smoking in Africa poses a growing cardiovascular health challenge due to rising smoker numbers despite marginal declines in prevalence, compounded by weak regulatory frameworks.
The projected increase in absolute numbers of tobacco smokers in Africa highlights an urgent need for aggressive enforcement of tobacco control policies to mitigate the rising burden of cardiovascular diseases.
May signal rising CVD burden in Africa; leaves open whether current policies can mitigate trends without prospective validation.
Background and Aims Tobacco smoking in Africa presents a significant public health challenge, particularly concerning cardiovascular health among young adults and men. While global smoking prevalence has declined, World Health Organization (WHO) projections estimate that the total number of tobacco smokers in Africa will rise from 57 million in 2015 to 67 million by 2025. This trend compounds the region's existing burden of cardiovascular diseases (CVDs). This narrative review aims to analyze tobacco smoking trends, elucidate the link between smoking and CVDs, evaluate implemented interventions, and assess policy responses across African nations. Methods This literature review was performed using electronic search databases comprising PubMed/MEDLINE, Google Scholar, and African Journals Online (AJOL). Using keywords and associated Boolean operators pertaining to “tobacco smoking”, “cardiovascular health”, and “Africa”, studies were selected based on their relevance and content quality. Studies focusing on tobacco use and CVD risks within African regions were included. Relevant references from regional public health and medical databases were also included. Results While relative smoking prevalence has experienced marginal declines, the absolute number of tobacco users in Africa is projected to rise significantly. This is due to rapid population growth, demographic shifts, and commercial determinants such as aggressive industry marketing and weak regulatory frameworks. This trend worsens CVDs like heart attacks, strokes, and hypertension. Interventions such as public awareness campaigns, graphic warning labels, and progressive taxation show promise but suffer from inconsistent enforcement. Conclusion Addressing these trends requires evidence‐driven policy enforcement and multi‐sectoral collaboration to mitigate tobacco smoking‐related cardiovascular risks. Prioritizing targeted interventions for vulnerable populations remains critical to reducing projected regional health and economic burdens.
No takes yet. Share an insight, caveat, or question.
Fatokun et al. (2026) conducted a review in Tobacco smoking and cardiovascular diseases (n=27). Tobacco smoking was evaluated. The absolute number of tobacco smokers in Africa is projected to rise significantly by 2025, exacerbating cardiovascular disease risks and necessitating aggressive, evidence-driven policy enforcement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: